Rigorous review process leads to accreditation for peripheral blood collection under high quality care for patients
South Texas Blood & Tissue has received accreditation of its Apheresis Center by the Foundation for the Accreditation of Cellular Therapy (FACT), which sets worldwide standards for care in cellular therapy.
Since 2009, the Apheresis Center has been collecting peripheral blood stem cell donations for the treatment of leukemia, lymphoma and other blood disorders. The FACT accreditation is for peripheral blood cellular therapy product collection.
“We wanted to achieve FACT accreditation for South Texas Blood & Tissue to reinforce the high standards of excellence that our center delivers and to better support our customers in the field of cell therapy,” said Adrienne Mendoza, Chief Operating Officer of South Texas Blood & Tissue, a subsidiary of San Antonio nonprofit BioBridge Global.
“We believe FACT accreditation is an important prerequisite to a clinical program in this field, and our donors and patients can be assured that our facility achieves the highest quality care in cell therapy treatment programs.”
FACT, which is based at the University of Nebraska Medical Center, is an internationally recognized accrediting body for hospitals and medical institutions offering stem cell transplant. A FACT accreditation indicates that South Texas Blood & Tissue has met the most rigorous standards in peripheral blood cellular therapy product collection.
FACT standards are set by international teams of experts who are dedicated to the improvement and progress of cellular therapy.
Standards are developed by consensus within committees consisting of knowledgeable clinicians, scientists, technologists and quality experts in cell manufacturing. International leaders in cellular therapy programs, cord blood banks, and registries serve on the Standards Development committees.
Liaison representation from consumers and regulatory bodies are consulted throughout the development process.
